TWST · Twist Bioscience Corp
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-12 | Leproust Emily M. |
Director |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Direct)
20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |
Employee Stock Option (right to buy)
|
19,952 |
| 2026-08-12 | Leproust Emily M. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. |
Common Stock
|
19,952 |
| 2026-08-12 | BLAKE KATRYN |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares sold by the Reporting Person to cover tax liability in connection with the vesting of Restricted Stock Units. This "sell to cover" transaction was made pursuant to a prior election by the Reporting Person and does not represent a discretionary trade by the Reporting Person. |
Common Stock
|
2,240 |
| 2026-08-12 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. Represents the weighted average sales price per share. The shares sold at prices ranging from $125.00 to $125.25 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
19,952 |
| 2026-08-10 | Leproust Emily M. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. |
Common Stock
|
113,318 |
| 2026-08-10 | Leproust Emily M. |
Director |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Direct)
20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |
Employee Stock Option (right to buy)
|
113,318 |
| 2026-08-10 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. Represents the weighted average sales price per share. The shares sold at prices ranging from $125.00 to $125.51 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
113,318 |
| 2026-08-07 | CHESS ROBERT |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 8, 2026. |
Common Stock
|
18,417 |
| 2026-08-07 | CHESS ROBERT |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 8, 2026. |
Common Stock
|
18,417 |
| 2026-08-07 | CHESS ROBERT |
Director |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 8, 2026. The option is immediately exercisable. 10% of the shares subject to the option vested on September 13, 2018, 15% of the shares subject to the option vested on March 24, 2019, and 1/48th of the shares subject to the option vested on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |
Stock Option (right to buy)
|
18,417 |
| 2026-08-05 | Cho Dennis |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2026. |
Common Stock
|
14,205 |
| 2026-08-03 | Cho Dennis |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
1,070 |
| 2026-08-03 | Finn Patrick John |
President and COO |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
2,888 |
| 2026-08-03 | WERNER ROBERT F. |
Chief Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
167 |
| 2026-08-03 | Green Paula |
SVP of Human Resources |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
1,133 |
| 2026-08-03 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
5,101 |
| 2026-07-23 | Finn Patrick John |
President and COO |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
2,238 |
| 2026-07-09 | Laponis Adam |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
2,399 |
| 2026-06-25 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. |
Common Stock
|
18,880 |
| 2026-06-24 | Cho Dennis |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2026. |
Common Stock
|
14,205 |
| 2026-06-22 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
1,688 |
| 2026-06-22 | Cho Dennis |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
346 |
| 2026-06-22 | Green Paula |
SVP of Human Resources |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
291 |
| 2026-06-15 | Green Paula |
SVP of Human Resources |
Convert↑
|
Common Stock
|
26,137 |
| 2026-06-15 | Green Paula |
SVP of Human Resources |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the weighted average sales price per share. The shares sold at prices ranging from $82.10 to $82.18 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
2,028 |
| 2026-06-15 | Green Paula |
SVP of Human Resources |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Direct)
25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |
Employee Stock Option (right to buy)
|
26,137 |
| 2026-06-15 | Green Paula |
SVP of Human Resources |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the weighted average sales price per share. The shares sold at prices ranging from $81.06 to $81.995 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
24,109 |
| 2026-06-08 | Cho Dennis |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
402 |
| 2026-06-08 | WERNER ROBERT F. |
Chief Accounting Officer |
Sell↓
|
Common Stock
|
1,127 |
| 2026-06-08 | Green Paula |
SVP of Human Resources |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
884 |
| 2026-06-08 | WERNER ROBERT F. |
Chief Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
232 |
| 2026-06-08 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
2,265 |
| 2026-06-08 | WERNER ROBERT F. |
Chief Accounting Officer |
Gift↓
Filing footnotes — Common Stock (Direct)
Represents a bona fide gift of shares to a charitable organization. |
Common Stock
|
500 |
| 2026-05-29 | Cho Dennis |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 7, 2025. |
Common Stock
|
14,205 |
| 2026-05-29 | Laponis Adam |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 8, 2025. |
Common Stock
|
4,000 |
| 2026-05-28 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. Represents the weighted average sales price per share. The shares sold at prices ranging from $68.240 to $69.190 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
6,465 |
| 2026-05-28 | Starovasnik Melissa A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on November 22, 2025. |
Common Stock
|
2,500 |
| 2026-05-28 | Leproust Emily M. |
Director |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |
Employee Stock Option (right to buy)
|
16,470 |
| 2026-05-28 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. Represents the weighted average sales price per share. The shares sold at prices ranging from $67.240 to $68.2375 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
7,623 |
| 2026-05-28 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. Represents the weighted average sales price per share. The shares sold at prices ranging from $66.240 to $67.210 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
900 |
| 2026-05-28 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. Represents the weighted average sales price per share. The shares sold at prices ranging from $65.00 to $65.820 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
1,482 |
| 2026-05-28 | Leproust Emily M. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. |
Common Stock
|
16,470 |
| 2026-05-27 | Leproust Emily M. |
Director |
Convert↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |
Employee Stock Option (right to buy)
|
25,017 |
| 2026-05-27 | Leproust Emily M. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. |
Common Stock
|
25,017 |
| 2026-05-27 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. Represents the weighted average sales price per share. The shares sold at prices ranging from $65.00 to $65.93 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
23,752 |
| 2026-05-27 | Leproust Emily M. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. Represents the weighted average sales price per share. The shares sold at prices ranging from $66.09 to $66.72 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Common Stock
|
1,265 |
| 2026-05-26 | Leproust Emily M. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025. |
Common Stock
|
24,282 |
| 2026-05-26 | Starovasnik Melissa A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on November 22, 2025. |
Common Stock
|
500 |
| 2026-05-26 | WERNER ROBERT F. |
Chief Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Common Stock
|
800 |
| 2026-05-26 | Leproust Emily M. |
Director |
Convert↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |
Employee Stock Option (right to buy)
|
24,282 |